Chemours Company (The) (CC) SVP David C. Shelton Sells 13,397 Shares of Stock

Chemours Company (The) (NYSE:CC) SVP David C. Shelton sold 13,397 shares of the business’s stock in a transaction on Tuesday, October 10th. The shares were sold at an average price of $55.00, for a total transaction of $736,835.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

David C. Shelton also recently made the following trade(s):

  • On Thursday, August 31st, David C. Shelton sold 13,337 shares of Chemours Company (The) stock. The shares were sold at an average price of $48.48, for a total transaction of $646,577.76.

Chemours Company (The) (NYSE:CC) last announced its earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.49 billion. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The firm’s quarterly revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.27 earnings per share.

The firm also recently announced a quarterly dividend, which was paid on Friday, September 15th. Shareholders of record on Thursday, August 17th were given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.22%. The ex-dividend date of this dividend was Tuesday, August 15th. Chemours Company (The)’s payout ratio is currently 8.11%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Stock Observer and is owned by of Stock Observer. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thestockobserver.com/2017/10/13/chemours-company-the-cc-svp-david-c-shelton-sells-13397-shares-of-stock.html.

A number of research analysts recently issued reports on CC shares. Jefferies Group LLC restated a “buy” rating and set a $48.00 target price on shares of Chemours Company (The) in a research report on Friday, June 16th. BidaskClub downgraded shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a research report on Saturday, June 17th. Citigroup Inc. upgraded shares of Chemours Company (The) from a “neutral” rating to a “buy” rating and boosted their target price for the company from $43.00 to $45.00 in a research report on Wednesday, July 5th. Zacks Investment Research downgraded shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a research report on Wednesday, July 12th. Finally, J P Morgan Chase & Co boosted their target price on shares of Chemours Company (The) to $55.00 and gave the company an “overweight” rating in a research report on Friday, August 4th. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $52.75.

Hedge funds and other institutional investors have recently modified their holdings of the company. Victory Capital Management Inc. grew its holdings in shares of Chemours Company (The) by 292.0% during the second quarter. Victory Capital Management Inc. now owns 657,810 shares of the specialty chemicals company’s stock worth $24,944,000 after buying an additional 489,990 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its holdings in shares of Chemours Company (The) by 264.7% during the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 42,669 shares of the specialty chemicals company’s stock worth $1,618,000 after buying an additional 30,970 shares in the last quarter. Virginia Retirement Systems ET AL purchased a new stake in shares of Chemours Company (The) during the second quarter worth about $1,460,000. Alps Advisors Inc. purchased a new stake in shares of Chemours Company (The) during the second quarter worth about $202,000. Finally, ING Groep NV purchased a new stake in shares of Chemours Company (The) during the second quarter worth about $6,630,000. Institutional investors and hedge funds own 72.90% of the company’s stock.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Insider Buying and Selling by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply